On Feb 10, 2022 Arkuda Therapeutics closed a Series B round and raised $64,000,000 from Atlas Venture, Cormorant Asset Management, Eli Lilly, Mission BioCapital, Pfizer Venture Investments, Pivotal bioVenture Partners, Surveyor Capital, Tekla Capital Management, featuring lead investors Cormorant Asset Management, Pivotal bioVenture Partners.

About the company: Arkuda Therapeutics is located at United States, North America.
“”

Company website: http://www.arkudatx.com